Corporate Report: 2017
About PharMedQuest Mission Statement Delivering the highest cost-effective care to patients by investing in optimal resources to build transformational & innovative tools, knowledge, and management for clinicians & payors.
Vision Statement Our vision is to energize and empower our healthcare communities to improve the lives of the patients we serve.
came and went, and based on the progress we made at PharMedQuest, we look forward to 2017 with great confidence and enthusiasm. We placed in the top 42% in the INC. Top 5000 fastest growing companies with a 142% growth rate. We are proud to have invested over $3.5 million in our team, technology, innovations and training. PharMedQuest focuses on delivering innovative solutions to our clients and positively impacting the communities we work in. On a daily basis, PharMedQuest strives to deliver a greater level of certainty for our clients in an uncertain healthcare environment. We are committed to providing our clients with high-quality, transparent deliverables. PharMedQuest would like to thank all of our clients, vendors, and most of all, our dedicated team for our journey into 2017. We are grateful, humbled, and eager to continue to earn our keep and to provide our best. Cheers, and please feel free to reach out to me or any of our team members with questions, requests or recommendations.
Chris Nee, PharmD, MBA CEO and President
â€œIt is a great privilege and honor for PharMedQuest to be included on the Inc. 5000 list of the fastest-growing private companies in America for 2016. This recognition is a reflection of the hard work, dedication and innovative thinking that each and every team member at PharMedQuest puts in on a daily basis.â€?
The PharMedQuest Team
PharMedQuest at a Glance (2016) We Have Invested Over $3.5 Million In Our Team Management Technology Pharmacy Technology
P340B® Reporting ACE - Clinical CRM
re P rof e
Managing > 1.5 Million Covered Lives
ARCTM 1.0 --> 2.0
87 Pharmacy Technicians
How does PharMedQuest Benefit Communities?
Quality of Care Focus
• • • •
340B Pharmacy Management Medical Benefit Management Full-Service Specialty Pharmacy Acute & Chronic Disease Patient Management
CLIENTS SERVED • • • •
Federally Qualified Health Centers Health Plans MSOs/IPAs Medical Groups
PUBLICATIONS White Paper Bend the Curve: A New Era for the Management of Specialty Pharmaceuticals (Access Market Intelligence) AMCP/ISPOR Posters USC PhD Fellow’s research posters covering HIV-ART guideline adherence and 340B generic drug utilization were accepted by and presented at AMCP and ISPOR
PHARMEDQUEST: AT A GLANCE
340B Management ®
The P340B® Difference: Clients Make Money Upon First Dollar of Revenue
2016 BY THE NUMBERS
Unique Patients Served
MANAGE BRAND AND GENERIC DRUGS
>892,964 Prescriptions Filled
Audit Success Rate (HRSA/CMS/PBM/ Joint Commission)
Over the past year, we secured three new Federally Qualified Health Center clients and opened five additional pharmacies. We are proud to share that we have expanded beyond our geographic area in the Los Angeles & Orange Counties to Merced & Stanislaus Counties in Central California. In addition to our physical expansion, our P340B® team has made a number of improvements to optimize our core services and provide advanced reporting & information to our clients. PharMedQuest continues its quest to provide quality, cost-effective pharmaceutical care and documented benefits to our clients. Thank you and we look forward to working with you in 2017.
Duane Saikami, PharmD, MBA Chief Operating Officer
• Outpatient Pharmacy • AIDS Drug Assistance Program (ADAP) • Hepatitis C • Sliding Fee Schedule (SFS) • Programs of All-Inclusive Care for the Elderly (PACE) • County-run Programs
CLIENTS SERVED • Federally Qualified Health Centers • Underserved Communities
HIV & HEP C PATIENTS SERVED
“We had two pharmacies onsite prior to replacing them with PMQ. The revenue and profit margin after the switch were significantly higher. Making the switch was a great decision.” COO of GVCH
P340B®: 340B MANAGEMENT
Medical Benefit Management Breaking New Grounds: The ARC Approach TM
2016 BY THE NUMBERS
Intervention Rate that Improved Care Quality
Drug-Specific Focus to Disease/Patient Focus
Peer-to-Peer Clinical Review
Single-Drug to Multi-Drug/ Holistic Approach
PMPM to PUPM Focus
ARC identifies the clinical & cost management opportunities for Medical & Pharmacy Benefit. TM
“They show where we are in providing high quality. Saves money. Reduces cost. They provide opportunities to improve care.” CMO of OMN
Let our team conduct a free claims analysis.
ARC™ had a busy year -- we optimized the ARC™ infrastructure, clinical evidence-based protocols, and workflow to ensure our services & reporting to our clients are transparent with added documentation. ARC™ continues to provide quality, cost-effective interventions for our patients, providers and payors. In 2017, we will publish research projects sharing our findings, accomplishments and collaborations with our clients.
Anthony Lam, MD, MHS Chief Medical Officer
CASE STUDY : MP00387 MSO
CLIENTS SERVED • Payors • Patients • Providers
• Health Plans • Medicare • Medicaid
COVERED DISEASE STATES • • • • • • •
Hematology/Oncology Rheumatology Endocrinology Infectious Diseases (HIV/HEP C) Neurology OB/GYN Others
500k Covered Lives
Per-utilizing member-per-month (PUPM) cost decreased at an average of 11% among top-10 diagnoses.
ARCTM: MEDICAL BENEFIT MANAGEMENT
50% of All Specialty Drug Costs Are Billed Through the Medical Benefit
700 E Birch St. #11055, Brea, CA 92822 • P: (714) 364-4008 F: (714) 364-4666 • PharMedQuest.com
© Copyright 2017 NS and Associates, LLC. All right reserved.
Neither this publication nor any part of it may be reproduced without written permission by NS and Associates, LLC.